DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study

The role of adjuvant therapy following resection of biliary tract cancer (BTC) remains unclear. We therefore evaluated the feasibility and toxicity of adjuvant gemcitabine in patients with BTC. This clinical phase II trial was an open-label, single center, single-arm study. Within 8 weeks after gros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Woo, Sang Myung, Yoon, Kyong-Ah, Hong, Eun Kyung, Park, Weon Seo, Han, Sung-Sik, Park, Sang-Jae, Joo, Jungnam, Park, Eun Young, Lee, Ju Hee, Kim, Yun-Hee, Kim, Tae Hyun, Lee, Woo Jin
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655294/
https://ncbi.nlm.nih.gov/pubmed/29113399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados